Mitsubishi Kagaku Bio-Clinical Laboratories, inc Report issue

For profit Phase 4
Founded: Kagaku Japan (1988)
Status: No NME R&D (1988)

Organization Overview

First Clinical Trial
2005
NCT00219570
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

clindamycin (cleocin) (1 trial)

levonadifloxacin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2